Literature DB >> 16715369

Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide.

Isabelle Bertholon1, Christine Vauthier, Denis Labarre.   

Abstract

PURPOSE: Biodistribution of intravenously administered nanoparticles depends on opsonization. The aim of this study was the evaluation of complement activation induced by nanoparticles coated with different polysaccharides. Influences of size and configuration of dextran, dextran sulfate, or chitosan bound onto nanoparticles were investigated.
METHOD: Core-shell nanoparticles were prepared by redox radical or anionic polymerization of isobutylcyanoacrylate in the presence of polysaccharides. Conversion of C3 into C3b in serum incubated with nanoparticles was evaluated.
RESULTS: Cleavage of C3 increased with size of dextran bound in "loops" configuration, whereas it decreased when dextran was bound in "brush." It was explained by an increasing steric repulsive effect of the brush, inducing poor accessibility to OH groups. The same trend was observed for chitosan-coated nanoparticles. Nanoparticles coated with a brush of chitosan activated the complement system lesser than nanoparticles coated with a brush of dextran. This was explained by an improved repelling effect. Dextran-sulfate-coated nanoparticles induced a low cleavage of C3 whereas it strongly enhanced protein adsorption.
CONCLUSION: Complement activation was highly sensitive to surface features of the nanoparticles. Type of polysaccharide, configuration on the surface, and accessibility to reactive functions along chains are critical parameters for complement activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715369     DOI: 10.1007/s11095-006-0069-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

1.  Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators.

Authors:  M Vittaz; D Bazile; G Spenlehauer; T Verrecchia; M Veillard; F Puisieux; D Labarre
Journal:  Biomaterials       Date:  1996-08       Impact factor: 12.479

2.  Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

Authors:  S K Law; N A Lichtenberg; R P Levine
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system.

Authors:  C Passirani; G Barratt; J P Devissaguet; D Labarre
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

4.  Blood protein adsorption onto chitosan.

Authors:  Johan Benesch; Pentti Tengvall
Journal:  Biomaterials       Date:  2002-06       Impact factor: 12.479

5.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

6.  Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system.

Authors:  H Sahli; J Tapon-Bretaudière; A M Fischer; C Sternberg; G Spenlehauer; T Verrecchia; D Labarre
Journal:  Biomaterials       Date:  1997-02       Impact factor: 12.479

7.  Mechanical, bioadhesive strength and biological evaluations of chitosan films for wound dressing.

Authors:  K Peh; T Khan; H Ch'ng
Journal:  J Pharm Pharm Sci       Date:  2000 Sep-Dec       Impact factor: 2.327

8.  Protein-rejecting ability of surface-bound dextran in end-on and side-on configurations: comparison to PEG.

Authors:  E Osterberg; K Bergström; K Holmberg; T P Schuman; J A Riggs; N L Burns; J M Van Alstine; J M Harris
Journal:  J Biomed Mater Res       Date:  1995-06

9.  Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles.

Authors:  Cédric Chauvierre; Denis Labarre; Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

10.  The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives.

Authors:  M P Carreno; D Labarre; M Jozefowicz; M D Kazatchkine
Journal:  Mol Immunol       Date:  1988-02       Impact factor: 4.407

View more
  25 in total

1.  Effects of block copolymer properties on nanocarrier protection from in vivo clearance.

Authors:  Suzanne M D'Addio; Walid Saad; Steven M Ansell; John J Squiers; Douglas H Adamson; Margarita Herrera-Alonso; Adam R Wohl; Thomas R Hoye; Christopher W Macosko; Lawrence D Mayer; Christine Vauthier; Robert K Prud'homme
Journal:  J Control Release       Date:  2012-06-23       Impact factor: 9.776

Review 2.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

Review 3.  Methods for the preparation and manufacture of polymeric nanoparticles.

Authors:  Christine Vauthier; Kawthar Bouchemal
Journal:  Pharm Res       Date:  2008-12-24       Impact factor: 4.200

Review 4.  Immunological risk of injectable drug delivery systems.

Authors:  Wim Jiskoot; Rianne M F van Schie; Myrra G Carstens; Huub Schellekens
Journal:  Pharm Res       Date:  2009-02-27       Impact factor: 4.200

Review 5.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

6.  New core-shell nanoparticules for the intravenous delivery of siRNA to experimental thyroid papillary carcinoma.

Authors:  Henri de Martimprey; Jean-Rémi Bertrand; Claude Malvy; Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2010-01-20       Impact factor: 4.200

Review 7.  Application of nanotechnologies for improved immune response against infectious diseases in the developing world.

Authors:  Michael Look; Arunima Bandyopadhyay; Jeremy S Blum; Tarek M Fahmy
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

Review 8.  Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Authors:  Eun Jung Cho; Hillary Holback; Karen C Liu; Sara A Abouelmagd; Joonyoung Park; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-03-21       Impact factor: 4.939

Review 9.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

Review 10.  Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles.

Authors:  Yamir Islam; Andrew G Leach; Jayden Smith; Stefano Pluchino; Christopher R Coxon; Muttuswamy Sivakumaran; James Downing; Amos A Fatokun; Meritxell Teixidò; Touraj Ehtezazi
Journal:  Adv Sci (Weinh)       Date:  2021-03-15       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.